The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Pharmacovigilance and Public Health
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Pharmacovigilance and Public Health.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacovigilance and Public Health.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Pharmacovigilance and Public Health are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
18. International Conference on Pharmacovigilance and Public Health has teamed up with the Special Journal Issue on
Pharmacovigilance and Public Health.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Selected Papers
-
Analysis of the Fire Hazard Posed by Petrol Stations in Stellenbosch and the Degree of Risk Acknowledgement in Land-Use Planning
K. Qonono
-
Clustering for Detection of Population Groups at Risk from Anticholinergic Medication
Amirali Shirazibeheshti, Tarik Radwan, Alireza Ettefaghian, Farbod Khanizadeh, George Wilson, Cristina Luca
-
The Risk Assessment of Cancer Risk during Normal Operation of Tehran Research Reactor Due to Radioactive Gas Emission
B. Salmasian, A. Rabiee, T. Yousefzadeh
-
Estimating Affected Croplands and Potential Crop Yield Loss of an Individual Farmer Due to Floods
Shima Nabinejad, Holger Schüttrumpf
-
Patient Support Program in Pharmacovigilance: Foster Patient Confidence and Compliance
Atul Khurana, Rajul Rastogi, Hans-Joachim Gamperl
-
Adverse Drug Reactions Monitoring in the Northern Region of Zambia
Ponshano Kaselekela, Simooya O. Oscar, Lunshano Boyd
-
Evaluation of Disease Risk Variables in the Control of Bovine Tuberculosis
Berrin Şentürk
-
The Evolving Customer Experience Management Landscape: A Case Study on the Paper Machine Companies
Babak Mohajeri, Sen Bao, Timo Nyberg
-
Production Structures of Energy Based on Water Force, Its Infrastructure Protection, and Possible Causes of Failure
Gabriela-Andreea Despescu, Mădălina-Elena Mavrodin, Gheorghe Lăzăroiu, Florin Adrian Grădinaru
-
Adopted Method of Information System Strategy for Knowledge Management System: A Literature Review
Elin Cahyaningsih, Dana Indra Sensuse, Wahyu Catur Wibowo, Sofiyanti Indriasari
-
Revisiting the Concept of Risk Analysis within the Context of Geospatial Database Design: A Collaborative Framework
J. Grira, Y. Bédard, S. Roche
-
Multidimensional and Data Mining Analysis for Property Investment Risk Analysis
Nur Atiqah Rochin Demong, Jie Lu, Farookh Khadeer Hussain
-
Identifying Corruption in Legislation using Risk Analysis Methods
Chvalkovska, J., Jansky, P., Mejstrik, M.
-
Combing LCIA and Fuzzy Risk Assessment for Environmental Impact Assessment
Kevin Fong-Rey Liu, Cheng-Wu Chen, Ken Yeh, Han-Hsi Liang
-
Negative Impact of Bacteria Legionella Pneumophila in Hot Water Distribution Systems on Human Health
Daniela Ocipova, Zuzana Vranayova, Ondrej Sikula
Digital Program consists of the e-proceedings book which is available online-only
and includes the conference communications (proceedings abstracts and papers).
Registered participants can access the digitally available conference
proceedings ( and certificates ) by visiting their profile pages.
Pharmacovigilance
Clinical development of medicines
Adverse drug reactions
Monitoring the safety of medicines
The aims of pharmacovigilance
Pharmacovigilance in practice
Pharmacovigilance in the regulation of medicines
Pharmacovigilance in clinical practice
Pharmacovigilance in public health
Absolute risk
Benefit - risk analysis
Causality assessment
Drug efficacy
Quality control in pharmacovigilance processes
Good pharmacovigilance practice
Pharmacovigilance risk management plans and new risk- benefit analysis tools
Pharmacokinetics and pharmacodynamics
Overview of clinical trials and post marketing
Clinical trials on various disorders
Biological activity of drugs
Abstracts/Full-Text Paper Submission Deadline |
|
August 01, 2024 |
Notification of Acceptance/Rejection |
|
August 15, 2024 |
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
August 09, 2024 |
Conference Dates |
|
September 05-06, 2024 |